Related Experiment Video

Updated: May 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

[Non oncologic applications of molecular targeted therapies]

Wassef Khaled1, Thibault de la Motte Rouge, Jean-Christophe Amirault

  • 1Groupe hospitalier Pitié-Salpêtrière - Charles-Foix, service d'oncologie médicale, Paris Cedex, France.

Bulletin Du Cancer
|October 25, 2012
PubMed

Insights

Molecular targeted therapies, initially developed for cancer, are now revolutionizing non-cancerous disease treatment. This review highlights key examples of these advanced treatments, showcasing the future of molecular medicine.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Advances in cancer biology have spurred the development of novel molecular targeted therapies.
  • Understanding non-cancerous disease physiology enables repurposing these targeted agents.

Purpose of the Study:

  • To review diverse strategies of molecular targeted therapies.
  • To illustrate the application of these therapies in non-cancerous diseases.

Main Methods:

  • Review of therapeutic strategies including monoclonal antibodies (receptor or ligand binding), tyrosine kinase inhibitors, and mTOR inhibitors.
  • Examples provided: Rituximab for rheumatoid arthritis, Bevacizumab for age-related macular degeneration, Imatinib for systemic sclerosis, and mTOR inhibitors for immunosuppression.

Main Results:

  • Demonstrated success of molecular targeted therapies in various non-cancerous conditions.
  • Highlighted the potential of these agents to treat a spectrum of diseases beyond cancer.

Conclusions:

  • Molecular targeted therapies represent a significant paradigm shift in medicine.
  • Clinical successes pave the way for the future of molecular medicine and personalized treatment approaches.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.